ITHACA, N.Y.--(BUSINESS WIRE)--April 7, 2006--Vybion (VY-bee-yon) announced the introduction of proprietary technologies that speed the development of therapeutic proteins and dramatically cut the time for biopharmaceuticals to reach the market. The Protein Evolution Tools have proven their capabilities with Vybion-developed proteins. The company plans to apply this technology in partnership with clients to improve both production yields and biological activity.
